HIGHLIGHTS
- who: Le Wang and collaborators from the Graduate School, Medical College, Nanchang University, Nanchang, Jiangxi, China, Scientific have published the article: FOXP1 inhibits pancreatic cancer growth by transcriptionally regulating IRF1 expression, in the Journal: PLOS ONE of July/11,/2022
- what: The authors report that PC patients with FOXP1 overexpression had a higher survival rate compared to patients with low- FOXP1 expression. In this study, the aim was to explore the biological function and clinical significance of FOXP1 in PC. This study has been approved by the Medical Ethics Committee of the institution .
-
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.